Unfortunately, an exclusive focus on TNBC may miss immunogenic estrogen receptor (ER)-positive breast cancers, a particular concern among Black patients, who have a higher frequency of basal-like breast cancer among ER-borderline (16) and who have higher rates of some types of genomic instability (17, 18). This evidence concerns the gene ESR1 and breast carcinoma.